ConductScience.org, home
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
API referenceFor AI assistants

Trial · NCT04184622

Participant flow56

How many started, completed or left each group, period by period.

1 to 20 of 56

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Primary Treatment PeriodSTARTEDPlacebo643
Primary Treatment PeriodSTARTED5 mg Tirzepatide630
Primary Treatment PeriodSTARTED10 mg Tirzepatide636
Primary Treatment PeriodSTARTED15 mg Tirzepatide630
Primary Treatment PeriodReceived at Least One Dose of Study DrugPlacebo643
Primary Treatment PeriodReceived at Least One Dose of Study Drug5 mg Tirzepatide630
Primary Treatment PeriodReceived at Least One Dose of Study Drug10 mg Tirzepatide636
Primary Treatment PeriodReceived at Least One Dose of Study Drug15 mg Tirzepatide630
Primary Treatment PeriodParticipants With Normoglycemia at RandomizationPlacebo373
Primary Treatment PeriodParticipants With Normoglycemia at Randomization5 mg Tirzepatide383
Primary Treatment PeriodParticipants With Normoglycemia at Randomization10 mg Tirzepatide374
Primary Treatment PeriodParticipants With Normoglycemia at Randomization15 mg Tirzepatide377
Primary Treatment PeriodParticipants With Prediabetes at RandomizationPlacebo270
Primary Treatment PeriodParticipants With Prediabetes at Randomization5 mg Tirzepatide247
Primary Treatment PeriodParticipants With Prediabetes at Randomization10 mg Tirzepatide262
Primary Treatment PeriodParticipants With Prediabetes at Randomization15 mg Tirzepatide253
Primary Treatment PeriodCOMPLETEDPlacebo509
Primary Treatment PeriodCOMPLETED5 mg Tirzepatide569
Primary Treatment PeriodCOMPLETED10 mg Tirzepatide566
Primary Treatment PeriodCOMPLETED15 mg Tirzepatide575

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04184622/flow

API referenceFor AI assistants